Bladder cancer can cause pain when it spreads to different areas of the body. From NSAIDs to nerve blocks, here are the ...

Being diagnosed with metastatic bladder cancer (or metastatic carcinoma) can be a uniquely isolating experience. It’s “a life-altering, day-to-day journey,” says Shanthi Sivendran, MD, senior vice ...

When you have metastatic bladder cancer, treatment plans often shift to address changes in the cancer, manage side effects, or take advantage of newer options. Even when medically necessary, making ...

The extent of the bladder cancer — how far it has spread — matters. Your care team needs to know if your cancer sits on or in the first lining of your bladder (non-muscle invasive), if it goes into ...

Integrative clinico-genomic evaluation of the human epidermal growth factor receptor 2 (HER2) in urothelial cancer (UC). EV-302: Long-term subgroup analysis from the phase 3 global study of enfortumab ...

The company now expects a longer path to approval than anticipated, leading it to deprioritize a therapy billed as a threat ...

KEYNOTE-B15 compared perioperative enfortumab vedotin plus pembrolizumab against neoadjuvant cisplatin-based chemotherapy in cisplatin-eligible MIBC, using event-free survival as the primary endpoint.

Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting ...

A growing body of research seeks to validate ctDNA as a means of guiding MIBC treatment, particularly immunotherapy.